{"article": [{"url": "https://www.marketwatch.com/story/greenwich-lifesciences-to-offer-1-mln-shares-in-planned-ipo-priced-at-750-to-850-each-2020-06-23", "published": 1592893280.0, "headline": "Greenwich LifeSciences to offer 1 mln shares in planned IPO, priced at $7.50 to $8.50 each", "body": "Greenwich LifeSciences GLSI, +2.04% set terms for its planned initial public offering on Tuesday, with plans to offer 1 million share priced at $7.50 to $8.50 a pop. The biotech has applied to list on Nasdaq, under the ticker symbol \"GLSI.\" A group of selling stockholders are also planning to sell 1.69 million shares in a separate offering. Aegis Capital is sole underwriter on the IPO. \"We are a biopharmaceutical company developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery,\" the company says in its prospectus. Proceeds of the deal will be used for clinical trials, manufacturing and general corporate purposes."}]}